In this episode of The Healthcare CEO Show, host Daniel Fernandez sits down with Dr. Rashmee Patil, hepatologist and Chief Medical Officer at Pinnacle Clinical Research. Dr. Patil shares her remarkable journey from running a solo clinical research site in an underserved Texas community to leading a multi-state organization that has grown from 3 to 14 sites.
She unpacks the highs and hurdles of building a business during the pandemic, selling to private equity, and stepping into a CEO role post-acquisition. Rashmee offers insights into de novo growth vs. M&A, how to scale without sacrificing culture or quality, and why integration strategy and leadership structure matter more than ever.
Plus, she discusses the growing role of AI in clinical trials, the importance of bringing more physicians into research, and how to prepare, mentally and operationally, for a successful exit. Whether you're navigating growth, considering acquisition, or leading through transition, this episode delivers valuable, real-world lessons on scaling with intention in the evolving healthcare landscape.
Powered by: https://Allegrow.com
👍 If you found this episode valuable, please LIKE, SHARE, and SUBSCRIBE for more interviews with inspiring healthcare leaders.
💬 Join the Conversation:
What’s your take on culture’s role in clinical outcomes? Share your thoughts in the comments!
🌐 Follow Us:
Facebook: https://facebook.com/allegrowagency
LinkedIn: https://linkedin.com/company/allegrowagency
Instagram: https://instagram.com/allegrowagency